In its annual report published on 17 May 2016, the European Medicines Agency (EMA) communicated the core tasks of the agency which include evaluating medicines, supporting research and development, and monitoring risks and side effects.


In 2015, the Agency recommended a total of 93 medicines for human use be given marketing authorisation. The report also contains interviews with several stakeholders and EMA representatives on topics such as data requirements from regulators, as well as collecting and dealing with big data and the risks and benefits associated with this.